Bioequivalence Study of Fosinopril 40mg Tablets Under Fasting Conditions
Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the relative bioavailability of fosinopril sodium
40 mg tablets (Ranbaxy Laboratories Limited, Lot No. 1238312) with that of Monopril® in
healthy adult subjects under fasting conditions.